GlassScriptPhysician profile
Dennis Hafford
NPI 1134357338
$2,019.66
in general payments reported to CMS, 2019-2025
24 companies · $570 in 2025
The $570 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $309 · 2023: $511 · 2024: $384 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $381.60 | 2021-2024 | Speedicath |
| Janssen Biotech, INC. | $214.83 | 2022-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $184.31 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $137.53 | 2023-2025 | Lithovue, Moses, Spaceoar Vue System - 10ml |
| Tolmar, INC. | $125.67 | 2023-2025 | Eligard, Jatenzo |
| Ferring Pharmaceuticals INC. | $113.88 | 2024-2025 | Adstiladrin |
| 180 Medical, INC. | $88.04 | 2022-2024 | Gentlecath |
| Urogen Pharma, INC. | $87.46 | 2023-2025 | Jelmyto |
| Olympus America INC. | $86.91 | 2022 | |
| Convatec INC. | $76.62 | 2023-2025 | |
| Procept Biorobotics Corporation | $72.03 | 2025 | |
| Abbvie INC. | $71.06 | 2022-2024 | |
| Teleflex LLC | $68.67 | 2022-2025 | Urolift, Barrigel |
| Medtronic, INC. | $62.93 | 2021-2024 | Interstim |
| Axonics, INC. | $50.85 | 2024 | Axonics, Bulkamid |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $33.31 | 2023 | Myrbetriq |
| Karl Storz Endoscopy-America | $31.03 | 2024 | Hopkins |
| Verity Pharmaceuticals INC. | $23.68 | 2025 | Trelstar |
| Myriad Genetic Laboratories, INC. | $20.87 | 2025 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $20.84 | 2025 | |
| Stryker Corporation | $19.63 | 2021 | |
| Allergan, INC. | $18.35 | 2021 | |
| Myovant Sciences INC. | $17.84 | 2022 | |
| Urovant Sciences INC | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Hafford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.